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To the editor
Biomedical data are being produced at an unprecedented rate owing to the falling cost of 
experiments and wider access to genomics, transcriptomics, proteomics and metabolomics 
platforms1,2. As a result, public deposition of omics data is on the increase. This presents 
new challenges, including finding ways to store, organize and access different types of 
biomedical data present on different platforms. We present the Omics Discovery Index 
(OmicsDI - http://www.omicsdi.org), an open source platform that enables access, discovery 
and dissemination of omics datasets.
In 2016, a group of researchers, publishers and research funders published the first 
guidelines to make data Findable, Accessible, Interoperable and Re-usable (FAIR - https://
www.force11.org/group/fairgroup/fairprinciples)3. The FAIR principles put specific 
emphasis on enhancing the ability of machines to automatically find and use the data, in 
addition to supporting its reuse. Challenges facing combined analyses of different datasets 
include achieving a common representation for datasets and their associated metadata, and 
the lack of protocols and tools that enable data exchange across multiple repositories. With 
respect to the first principle (‘Findable’), most of the available resources for the scientific 
community nowadays are either field specific, that is genomics, proteomics or metabolomics 
experimental datasets; or organism-specific, but including datasets from different omics 
technologies, e.g. the “Saccharomyces Genome Database” (SGD). Finding a dataset can be 
frustrated by the need to search individual repositories and read numerous publications. The 
development of consortia integrating resources e.g. ProteomeXchange and 
MetabolomeXchange has helped to improve findability. Nature1 and Nature Biotechnology4 
have highlighted the need for dataset integration frameworks to increase findability of data. 
And, in the context of the European ELIXIR (https://www.elixir-europe.org/) and USA Big 
Data to Knowledge (BD2K)5 trans-NIH initiative, it is clear that a dedicated platform, search 
engines and services enabling the aggregation of omics datasets, to resources such as 
PubMed6 or Europe PubMed Central (EuroPMC)7, is required.
The Omics Discovery Index (OmicsDI - http://www.omicsdi.org) is an open source platform 
that can be used to access, discover and disseminate omics datasets. OmicsDI can integrate 
proteomics, genomics, metabolomics, and transcriptomics datasets (Fig. 1). To date, eleven 
repositories have agreed on a common metadata structure framework and exchange format, 
and have contributed to OmicsDI (Supplementary Notes 1–3), including proteomics 
databases (the PRoteomics IDEntifications (PRIDE) database, PeptideAtlas, the Mass 
spectrometry Interactive Virtual Environment (MassIVE) and the Global Proteome Machine 
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Database (GPMDB)); metabolomics databases (MetaboLights, the Global Natural Products 
Social Molecular Networking project (GNPS), MetabolomeExpress, and the Metabolomics 
Workbench), the major European Genome-Phenome Archive (EGA) and transcriptomics 
databases (ArrayExpress and Expression Atlas). OmicsDI stores biological and technical 
metadata from these public datasets using an efficient indexing system (Fig. 1b) which can 
integrate different biological entities including genes, transcripts, proteins, metabolites and 
the corresponding publications from PubMed.
In order to facilitate participation in OmicsDI by repositories and the future integration of 
other omics fields (e.g. interactomics) we have developed a set of data integration guidelines 
and metadata requirements. The level of annotation required is flexible and many 
repositories only provide a subset of the metadata included in our guidelines. Data with 
varying amounts of annotation can be made ‘Accessible’ in OmicsDI by using a flexible 
metadata schema that classifies datasets as either mandatory, recommended or additional. A 
flexible exchange system based on the OmicsDI XML format and application programming 
interfaces (APIs) has been developed. Each repository needs to generate these file formats to 
join the OmicsDI platform. In order to facilitate integration, a stand-alone open source Java 
tool has been developed (‘OmicsDI XML validator’). It allows the detection of metadata 
related format errors as well as inconsistencies in the dataset representation (Supplementary 
Note 4).
Different repositories use their own data models, metadata representation and identifiers, e.g. 
controlled vocabularies (CVs) and ontologies. To address any interoperability problems that 
arise, OmicsDI includes a metadata normalization and annotation expansion step for every 
dataset that is integrated (Fig. 1b). These harmonization steps standardize experimental and 
technical metadata, the identifiers for the biological entities, and the references to external 
resources. For example, for any publication named using the Digital Object Identifier (DOI) 
or a citation, the matching PubMed identifier is inserted during harmonization 
(Supplementary Notes 5–6). If the name of an organism is provided using free-text the 
annotation step during harmonization converts it to an NCBI taxonomy identifier. Different 
datasets can include different terms for the same concept within the same context8 e.g. a 
protein can also be referred to as a gene product. To overcome this type of problem, an 
ontology-based annotation expansion step is applied using the ontology tool ‘Annotator’9, 
and every relevant phrase in the metadata (title, description, sample and protocols) and the 
corresponding publication (title and abstract) is enriched with the relevant synonyms, 
ontology and CV terms.
OmicsDI is a lightweight discovery tool that comprises more than 81,116 omics datasets 
(December 2016) from eleven different repositories and includes four omics types 
(transcriptomics: 67,361; proteomics: 6,281; genomics: 8,093; and metabolomics: 847). The 
number of datasets from human, model organisms and non-model organisms (excluding 
human) is uniformly distributed among repositories and omics types (Fig. 2a), highlighting 
the diversity of datasets. To the best of our knowledge, OmicsDI is the first resource that 
integrates datasets from different omics fields and databases into one framework and web 
interface.
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OmicsDI also extends the ‘Findable’ principle by providing methods to find and link 
existing datasets. The annotation expansion step using synonyms enables users to find and 
associate datasets that cannot otherwise be found. For example, the proteomics dataset 
PXD002530 (http://www.ebi.ac.uk/pride/archive/projects/PXD002530) can be found in 
OmicsDI with the search term ‘side effects’, whereas this dataset cannot be found by 
searching PRIDE using that term. In PRIDE it is only possible to find the same dataset by 
inputting the term ‘adverse effects’ that was used in the original annotation of the dataset. 
By indexing the biological entities information in OmicsDI it is possible to find datasets in 
which the queried molecule has been reported without an exact matched term. For example, 
the Metabolomics Workbench dataset ST000113 can be found in OmicsDI using the 
metabolite name ‘Arg-[13C,15N]3’, whereas the same search will not find ST000113 in 
Metabolomics Workbench.
OmicsDI links datasets by two methods. First, datasets are directly linked using explicit 
mentions in the metadata. If the dataset is a reanalysis (e.g. PeptideAtlas dataset) of a dataset 
in a different member repository (e.g. PRIDE), a cross-reference in the OmicsDI XML is 
used to define this relation. This annotation can be provided by the original repository in the 
OmicsDI XML (e.g. PeptideAtlas) or can be inferred by OmicsDI during the annotation 
process. As of December 2016, the relations ‘Reanalyzed by’ and ‘Reanalysis of’ are 
already in use (Supplementary Table 1). This mechanism provides a direct link between 
datasets in different repositories. Second, the publication associated with a dataset can be 
used to link datasets that are deposited in different repositories. This enabled the linking of 
datasets from different databases that are however part of the same multi-omics experiment 
(Fig. 2b) and presents them to the user as ‘Other related omics datasets in’. As of December 
2016, 4,476 datasets have been labeled by the OmicsDI annotation component as part of 
multi-omics experiments. While still small (5% of all OmicsDI datasets), the number of 
multi-omics datasets is growing (Supplementary Table 2).
OmicsDI also uses the ‘similar dataset’ concept (Supplementary Note 7). The concept of 
‘Related article’ has been applied in PubMed to explore topics10. In OmicsDI, similar 
datasets are computed at two different levels: metadata and biological entities. Both 
similarity levels are estimated by comparing the weighted term vectors of each dataset using 
the dot (scalar) product. The distribution of the metadata similarity (Supplementary Fig. 1) 
and molecular similarity (Supplementary Fig. 2) are filtered depending of the distribution for 
each omics type. In this way OmicsDI boosts the discoverability of related datasets that use 
similar analytical protocols, software (Supplementary Fig. 3), or share similar biological 
entities (Supplementary Fig. 4). To our knowledge, this enables for the first time the 
association of related datasets stored in different resources. For example, for the Expression 
Atlas dataset E-GEOD-30999 (http://www.omicsdi.org/dataset/atlas-experiments/E-
GEOD-30999), OmicsDI reports 14 related datasets. In addition, the ‘biological similarity’ 
score computes the number of shared biological entities among datasets without taking into 
account additional metadata. For example, the same dataset has five datasets with a 
biological similarity score above 0.5 and one dataset with a score of 0.7 (E-GEOD-41662). 
Of these, dataset E-GEOD-41663 is not classified as related by the metadata-based 
similarity, although careful reading of the associated manuscripts reveals that E-
GEOD-41663 used a subset of the samples of E-GEOD-30999. This example demonstrates 
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the value of our approach. We determined the correlation between metadata and biological 
similarity scores for all OmicsDI datasets (Fig. 2c). The results showed no correlation (R2 = 
0.03) between both metrics across all types of omics datasets, with the highest correlation 
found in metabolomics approaches (R2 = 0.3). For example, the datasets PXD000637 
(PRIDE), ST000189 (Metabolomics Workbench), and E-MTAB-3839 (Expression Atlas) 
showed a higher biological similarity score (above 0.85) and less than 5 of metadata score 
(Fig. 2c). These results show that both scores are orthogonal metrics supporting discovery of 
related datasets through complementary methods.
The OmicsDI web interface provides different views each of which focuses on a specific 
aspect of the data (Supplementary Notes 8–9). A metadata overview and access statistics 
provide a convenient entry point to browse a repository (Supplementary Fig. 5). Datasets can 
be searched and filtered based on annotations (e.g. species, tissue, disease), year of 
publication, or repository. The result of each search displays all the relevant datasets sorted 
using a weighted scoring function (Supplementary Fig. 6). In addition, OmicsDI provides a 
dataset page that includes a list of related publications and similar datasets (Fig. 2b–d). If the 
biological entities information is available for a given dataset, a chord diagram presents the 
link to related datasets with high biological similarity scores (Fig. 2d). A web service 
interface, including a standard RESTful API to access the data programmatically, is also 
provided (http://www.omicsdi.org/ws). Related libraries and packages used for OmicsDI are 
also available at https://github.com/BD2K-DDI. For instance, an R-package called ddiR is 
provided, enabling data analysis (Supplementary Note 10).
OmicsDI exploits advances in metadata-based browsing to support dataset findability. The 
original datasets are not replicated, but are referenced. In addition to fully open datasets, life 
science often produces valuable datasets containing personal identifiable genetic or 
phenotypic data. These data are deposited in controlled-access repositories, to which access 
is granted after application to a data access committee (DAC). However, the metadata of 
controlled –access repositories is accessible, and therefore OmicsDI can integrate data from 
EGA (the first controlled-access repository with open, searchable metadata). The 
responsibility for provision of well-formatted metadata lies with the original data providers 
(similar to the concept of publisher data provision to PubMed). OmicsDI displays and 
promotes the original dataset identifiers, not only to avoid creation of another set of 
identifiers, but also to ensure attribution of credit to the original data providers. OmicsDI can 
integrate with large, broader scope efforts like the Biomedical healthCAre Data Discovery 
and Index Ecosystem (bioCADDIE) through shared metadata formats.
In conclusion, Omics DI provides an integrated search framework for datasets that 
introduces a range of modern features such as access metrics and discovery of related 
datasets that we now take for granted in PubMed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Omics Discovery Index: data standardization, annotation, index and presentation. (a) The 
datasets stored in public repositories are converted to a common data representation 
including all metadata and biological entities. The OmicsDI XML files are validated using 
the OmicsDI XML validator. (b) The OmicsDI XML files are then annotated using public 
services and databases like UniProt, ChEBI, and PubMed, and the metadata is enriched 
using the Annotator service. The EBI search engine generates the indexes including other 
related resources such as PubMed, UniProt, Ensembl and ChEBI. (c) Different clients can 
use the OmicsDI API to retrieve data from the resource including the web interface and the 
ddiR package.
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Figure 2. 
Distributions of OmicsDI datasets. (a) Distribution of datasets per omics type and organism 
category including model organisms, non-model organisms (excluding human) and human. 
(b) The dataset view showing the other related omics datasets, including the ontology 
highlighting option to extract the most relevant terms in the metadata. (c) Pearson-
correlation plot between the metadata similarity score and the biological similarity score, 
across transcriptomics (T), proteomics (P) and metabolomics (M) datasets. (d) The shared 
molecules box shows all datasets with a biological similarity score of more than 0.5, with a 
slider allowing a user to increase the cutoff value (here set to 0.81).
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